Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ONEG | OneConstruction Group | $4.95 | -$5.31 | -51.74% | 2.5M | $164.2M | $1.48$13.50 |
| TSSI | Tss | $8.66 | -$6.59 | -43.21% | 189.4K | $432.6M | $5.63$31.94 |
| GWH | ESS Tech | $2.66 | -$1.59 | -37.41% | 1.5M | $83.4M | $0.76$13.87 |
| AVXL | Anavex Life Sciences | $3.71 | -$1.98 | -34.80% | 19.1M | $488.7M | $2.86$14.44 |
| GAUZ | Gauzy | $2.82 | -$1.20 | -29.85% | 831.4K | $75.3M | $1.98$13.00 |
| SGBX | Safe & Green | $2.25 | -$0.91 | -28.80% | 3.1M | $1.5M | $1.81$122.88 |
| ATGL | Alpha Technology Group | $10.05 | -$3.95 | -28.21% | 63 | $213.7M | $8.79$57.32 |
| SOC | Sable Offshore | $4.24 | -$1.65 | -28.01% | 11.1M | $586.1M | $4.04$35.00 |
| STUB | StubHub | $14.10 | -$4.72 | -25.08% | 12.8M | $6.9B | $12.91$27.89 |
| FOXX | Foxx Development | $2.60 | -$0.65 | -20.04% | 24.3K | $22.0M | $2.45$11.00 |
Related Articles
Featured Article
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value
David Jagielski|Mar 15, 2023
The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.
Is Anavex Life Sciences Stock a Buy Now?
David Jagielski|Feb 23, 2023
A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business.
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run
George Budwell|Feb 9, 2023
Short-sellers have piled into this clinical-stage biopharma stock.
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
Alex Carchidi|Dec 17, 2022
The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.
Is Anavex Life Sciences a Buy?
Alex Carchidi|Dec 13, 2022
It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.
Is Anavex Life Sciences a Smart Stock to Buy Now?
Cory Renauer|Dec 3, 2022
The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?
2 Biotech Stocks Set to Go Supernova Soon
George Budwell|Oct 18, 2021
Anavex Life Sciences and Affimed both sport unique drug development platforms that could be worth billions.
Cryptocurrencies Are Going Nuts in 2021, Sending These Stocks Higher Today
Jon Quast|Jan 4, 2021
Investor excitement is being fueled by rising crypto prices, but can this alone sustain the long-term returns of bitcoin mining and mining hardware stocks?
3 Biotech Stocks That Have Already Doubled This Year
Cory Renauer|Feb 20, 2020
Can these soaring biotech stocks keep climbing?
Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys
Cory Renauer|Feb 1, 2017
The tiny biotech's only clinical-stage candidate is a long way from the goal line, making these two biotech stocks far better picks.
